BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:The 5th World ADC Summit South Korea (9-11 June 2026 | Seoul) is Asia's premier meeting dedicated to accelerating next-generation antib ody drug conjugate (ADC) development. As part of the broader World Target ed Therapeutics Summit South Korea\, it sits alongside the World TPD and Induced Proximity Summit South Korea and the World Bispecifics and T-Cell Engager Summit South Korea\, creating a unified hub for cutting-edge tar geted therapeutics innovation.\n\nThe event brings together more than 300 experts from Korean and global biopharma to address the country's rapid shift from biosimilars toward high-value\, first- and best-in-class ADCs. With novel payloads\, dual-payload platforms\, bispecific ADCs\, and str ategies to overcome Topo-1 resistance at the forefront\, the summit provi des end-to-end insights across discovery\, preclinical and clinical devel opment\, and CMC. Attendees gain access to three dedicated ADC content tr acks\, two pre-conference days\, and additional sessions on bispecifics\, T-cell engagers\, and targeted protein degradation.\n\nFeaturing 35+ spe akers from organizations such as Daiichi Sankyo\, Astellas\, Pfizer\, Abb Vie\, and Kanaph Therapeutics\, the summit offers unmatched opportunities for scientific exchange\, partnership building\, and technology showcasi ng. As part of the co-located World Targeted Therapeutics Summit\, it pla ys a central role in establishing South Korea as a rising global hub for precision-driven cancer therapeutics.\n\nURLs:Website: \;https://go.e vvnt.com/3474355-0?pid=185Tickets: \;https://go.evvnt.com/3474355-2?p id=185Brochure: \;https://go.evvnt.com/3474355-3?pid=185\n\nPrices:Dr ug Developer Pricing - 3 Day Pass (Workshop Day + Conference): USD 2548.0 0\,Drug Developer Pricing - 2 Day Pass (Conference Only): USD 1849.00\,Ac ademic Pricing - 3 Day Pass (Workshop Day + Conference): USD 2298.00\,Aca demic Pricing - 2 Day Pass (Conference Only): USD 1649.00\,Service Provid er Pricing - 3 Day Pass (Workshop Day + Conference): USD 5198.00\,Service Provider Pricing - 2 Day Pass (Conference Only): USD 3899.00\n\nSpeakers : \;Alireza Tafazzol\, Senior Scientist II\, AbbVie\, Daniel Milano\, Senior Director\, ADC Process Development and MSAT\, AbbVie\, Johanna Mi delet\, Head\, Bioconjugation and Chemistry\, Abzena\, Romain Bertrand\, Director\, ADC Chemistry\, Araris\, Yu-Shin Hsu\, Research Analyst Lead\, Beacon by Hanson Wade\, Giorgio Salciarini\, Head\, Sales and Technical Business Development\, BSP Pharmaceuticals\, John Flygare\, Head of Large Molecule and ADC Innovation\, Eli Lilly\, Brandon Coyle\, Director of Pi votal Process Development\, Gilead\, Ertan Eryilmaz\, Vice President\, In duPro\, Eugenio Cardenal Vigil\, Senior Principal Scientist II CMC Regula tory Affairs\, Janssen Biologics\, Anette Sommer\, Head\, R and D\, Lonza \, Zhaohui Sunny Zhou\, Professor and Faculty Fellow\, Northeastern Unive rsity\, Chris Neumann\, Senior Director\, Head of ADC Chemistry\, Pfizer\ , Gregory Szeto\, Scientific Director\, Pfizer\, Matt Levengood\, Directo r\, ADC Engineering\, Pfizer\, Karsten Hartvigsen\, Scientist\, Servier S ymphogen\, Olivier Marcq\, Senior Vice President\, CMC\, Tubulis\, Marc-A ndre Kasper\, Vice President\, Chemistry and Early Discovery\, Tubulis\, Jimmy Li\, Chief Executive Officer\, Wuxi XDC\, Rafael Amado\, President\ , Zai Lab\, Jinwon Jung\, Senior Director\, ABL Bio\, Nam-Gu Her\, Chief Executive Officer\, Aimed Bio\, Pedro Lee\, Head of Biology\, CrossPoint Therapeutics\, Tae Hwan Kim\, Associate Professor\, College of Pharmacy\, Daegu University\, Joseph Kim\, Senior Vice President\, Kanaph Therapeut ics\, Shawn (Sang) Hyun Lee\, Vice President\, Orum Therapeutics\, Jin-Sa n Yoo\, President\, R and D\, PharmAbcine\, Doo Young Jung\, Chief Execut ive Officer\, Pinot Bio\, Won Gyun Ahn\, Associate Director\, Qurient\, S hawn Seong\, Chief Executive Officer\, Shaperon\, Jo Hae Park\, Head\, Bu siness Development and Licensing\, TriOar Biotechnology\, Michinori Akaiw a\, Senior Director and Head of ADC Biologics Engineering\, Oncology Rese arch\, Astellas\, Bin Zou\, Founder and Chief Executive Officer\, Axcynsi s\, Dongzhou Jeffrey Liu\, Chief Scientific Officer\, Head of R and D\, H uadong Medicine\, Guodu Liu\, Professor\, Inner Mongolia University\, Koj i Yashiro\, Director\, Pacific Business Development and Licensing\, Merck and Co\, Heidi Wang\, Chief Executive Officer\, OBI Pharma\, David Huang \, Senior Director\, Head of ADC Enabling Technologies\, OBI Pharma\, Wei -Han Lee\, Senior Director\, CMC\, OBI Pharma\, Yoshitsugu Shitaka\, Chie f Executive Officer\, RealizeEdge\, Kaisheng Huang\, Chief Operating Offi cer and Chief Quality Officer\, Remegen\, Nitin Damle\, Executive Vice Pr esident and Chief Innovation Officer\, Sun Pharma\, Gerold Meinhardt\, Vi ce President\, Asset and Portfolio Management\, Daiichi Sankyo\n\nCategor y: \;Conferences | Science\, Health and Medicine | Oncology\n\nDate a nd Time: \;9th June 2026 at 8:00 am to 11th June 2026 at 4:30 pm\n\nV enue details: \;COEX Seeds Le West\, Gangseo-gu\, Seoul\, Korea (Sout h)\n DTEND:20260611T163000 DTSTAMP:20260501T045225Z DTSTART:20260609T080000 LOCATION:COEX Seeds Le West\, Gangseo-gu\, Gangseo-gu\, Seoul\, SEQUENCE:0 SUMMARY:The 5th World ADC Summit South Korea (9-11 June 2026 | Seoul) is A sia's premier meeting dedicated to accelerating next-generation antibody drug con... UID:5c199ebc-7b2a-4705-b94e-ed28a81f98b5 END:VEVENT END:VCALENDAR